Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

The Effects of Virtual Reality-Based Relaxation on Postoperative Symptoms and Patient Satisfaction Among Adolescents Undergoing Emergency Surgery

16 novembre 2026 mis à jour par: Aynur Çakmak, Dokuz Eylul University

Investigation of the Effects of Virtual Reality-Based Relaxation Exercises on Postoperative Symptom Management and Patient Satisfaction in Adolescents Undergoing Emergency Surgical Intervention

The aim of this study is to evaluate the effects of virtual reality-based progressive relaxation exercises on surgery-related symptoms and patient satisfaction among adolescents undergoing emergency surgery. Specifically, the study will investigate the effects of these exercises on preoperative and postoperative anxiety levels, pain intensity scores, nausea and vomiting scores, time to mobilization (hours), total length of hospital stay (hours), and patient satisfaction.

Aperçu de l'étude

Description détaillée

The aim of this study is to evaluate the effects of virtual reality-based progressive relaxation exercises on surgery-related symptoms and patient satisfaction in adolescents undergoing emergency surgical procedures. Specifically, the study will examine the effects of this intervention on preoperative and postoperative anxiety levels, pain intensity, nausea and vomiting severity, time to first mobilization (hours), total length of hospital stay (hours), and patient satisfaction.

Type d'étude

Interventionnel

Inscription (Estimé)

60

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Sauvegarde des contacts de l'étude

Lieux d'étude

    • Balçova
      • Izmir, Balçova, Turquie (Türkiye)
        • Dokuz Eylül University Research and Application Hospital

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

12 ans à 18 ans (Enfant, Adulte)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Inclusion Criteria:
  • Adolescents aged 12-18 years who voluntarily agree to participate in the study,
  • Undergoing surgery for the first time,
  • Scheduled to undergo emergency surgery within 24 hours of hospital admission (appendicitis, ovarian torsion, testicular torsion, or Meckel's diverticulum),
  • Having no chronic diseases (e.g., diabetes, hypertension, asthma, cerebral palsy, epilepsy, cystic fibrosis, etc.),
  • Having no visual, hearing, or physical disabilities,
  • Being oriented to person, place, and time,
  • Having no cognitive impairment that would affect their ability to express themselves,
  • Adolescents for whom written informed consent has been obtained from both the adolescent and their parent.

Exclusion Criteria:

  • Adolescents who do not complete all stages of the study,
  • Adolescents who are admitted to the intensive care unit after surgery,
  • Adolescents whose surgery is postponed beyond the first 24 hours,
  • Adolescents who undergo surgery due to perforated appendicitis,
  • Adolescents diagnosed with migraine, vertigo, or similar conditions,
  • Adolescents who experience hemodynamic instability when wearing the VR headset.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Soins de soutien
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Intervention Group: Virtual Reality

Adolescents and their parents will be informed about the study, and written informed consent will be obtained. Baseline data will be collected using the Adolescent Descriptive Characteristics Form, Vital Signs Monitoring Form, Visual Analog Scale (VAS), and Spielberger State Anxiety Inventory (STAI-S). Participants will receive instructions on VR headset use and relaxation exercises. Before surgery, vital signs, pain, and anxiety will be reassessed. Postoperatively, vital signs, pain, anxiety, and nausea (BARF scale) will be evaluated. At the fourth postoperative hour, following adequate recovery from anesthesia, the VR-based relaxation intervention will be administered. All clinical outcomes will be reassessed at the sixth postoperative hour. Before discharge, patient satisfaction (VAS-S), time to first mobilization, and length of hospital stay will be recorded.

The virtual reality (VR) intervention was implemented using an Oculus Quest 2 headset, selected to ensure patient safety and ease of use. The device is rechargeable, operates independently without requiring a computer connection, weighs 503 g, and is secured to the user's head using adjustable, soft straps. Its hand-tracking feature enables participants to interact naturally with virtual environments using their own hands, without the need for handheld controllers.

The VR-based relaxation program lasts 16 minutes and incorporates rhythmic breathing, controlled exhalation, and progressive muscle relaxation exercises. The progressive muscle relaxation component targets several muscle groups, including the arms and hands, neck, chest and abdomen, legs and hips, back and shoulders, eyes and head, and feet and lower legs.

Aucune intervention: Control Group: Standard Care

During the preoperative period, adolescents and their parents will be informed about the surgical process, and appropriate measures will be taken to ensure patient safety. Adolescents and their parents will also be informed about the study, and written informed consent will be obtained from both parties. During the initial face-to-face interview, data will be collected using the Adolescent Descriptive Characteristics Form, Vital Signs Monitoring Form, Visual Analog Scale (VAS), and Spielberger State-Trait Anxiety Inventory - State Version (STAI-S). Demographic and clinical data will be obtained from the adolescents, their parents, and medical records. Before surgery, vital signs, pain intensity, and state anxiety levels will be reassessed. At the fourth postoperative hour, vital signs, pain intensity, state anxiety, and nausea will be assessed using the BARF scale, while routine nursing care will be provided. At the sixth postoperative hour, these clinical outcomes will be reassessed.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Preoperative Anxiety Level
Délai: 6 months

Anxiety will be assessed using the Spielberger State Anxiety Inventory (STAI-S), a 20-item scale with total scores ranging from 20 to 80, with higher scores indicating higher levels of anxiety. Two assessments will be conducted during the preoperative period: the first immediately upon the patient's arrival at the surgical ward and the second 30 minutes before transfer to the operating room.

6 months
Postoperative Anxiety Level
Délai: 6 months

Postoperative anxiety will be assessed on postoperative day 0 using the Spielberger State Anxiety Inventory (STAI-S), a 20-item self-report instrument scored on a 4-point Likert scale, with total scores ranging from 20 to 80. Higher scores indicate greater levels of postoperative anxiety. Assessments will be conducted at two time points: 4 and 6 hours after surgery (postoperative day 0).

6 months
Postoperative Pain Intensity
Délai: 6 months

Postoperative pain intensity will be assessed on postoperative day 0 (POD 0) using a 10-cm Visual Analog Scale (VAS), with scores ranging from 0 to 10. A score of 0 indicates no pain, whereas a score of 10 represents the worst imaginable pain. Assessments will be performed at 4 and 6 hours after surgery.

6 months

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Postoperative Nausea Severity
Délai: 6 months

Postoperative nausea severity will be assessed using the Baxter Retching Faces (BARF) Scale, with scores ranging from 0 to 10. A score of 0 indicates no nausea, whereas a score of 10 represents the most severe nausea. Assessments will be conducted at two time points: 4 and 6 hours after surgery.

6 months
Postoperative Length of Hospital Stay
Délai: 6 months

Total duration of postoperative hospitalization, measured in hours from the completion of the surgical procedure until the adolescent patient is formally discharged from the hospital.

6 months
Patient satisfaction level
Délai: 6 months

Visual Analog Scale for Satisfaction (VAS-S): Patient satisfaction with nursing care will be assessed using a 10-cm visual analog scale ranging from 0 (not satisfied at all) to 10 (completely satisfied), with higher scores indicating greater satisfaction. The assessment will be performed at the 6th postoperative hour on the day of surgery (POD 0).

6 months
At the First Postoperative Mobilization Session
Délai: 6 months

The total duration (in minutes) of active ambulation performed by the adolescent patient during the first postoperative mobilization session on postoperative day 0 (POD 0).

6 months

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

20 novembre 2026

Achèvement primaire (Estimé)

10 avril 2027

Achèvement de l'étude (Estimé)

10 août 2027

Dates d'inscription aux études

Première soumission

4 novembre 2026

Première soumission répondant aux critères de contrôle qualité

16 novembre 2026

Première publication (Réel)

18 novembre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

18 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

16 novembre 2026

Dernière vérification

1 novembre 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • DEU-SBF-AC-01

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner